<SEC-DOCUMENT>0001628280-25-011736-index.html : 20250310
<SEC-HEADER>0001628280-25-011736.hdr.sgml : 20250310
<ACCEPTANCE-DATETIME>20250310170101
ACCESSION NUMBER:		0001628280-25-011736
CONFORMED SUBMISSION TYPE:	DEFA14A
PUBLIC DOCUMENT COUNT:		3
FILED AS OF DATE:		20250310
DATE AS OF CHANGE:		20250310

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CUMBERLAND PHARMACEUTICALS INC
		CENTRAL INDEX KEY:			0001087294
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				000000000
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		DEFA14A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-33637
		FILM NUMBER:		25724640

	BUSINESS ADDRESS:	
		STREET 1:		2525 WEST END AVENUE
		STREET 2:		SUITE 950
		CITY:			NASHVILLE,
		STATE:			TN
		ZIP:			37203
		BUSINESS PHONE:		615-255-0068

	MAIL ADDRESS:	
		STREET 1:		2525 WEST END AVENUE
		STREET 2:		SUITE 950
		CITY:			NASHVILLE
		STATE:			TN
		ZIP:			37203
</SEC-HEADER>
<DOCUMENT>
<TYPE>DEFA14A
<SEQUENCE>1
<FILENAME>a2024proxy-defa14a.htm
<DESCRIPTION>DEFA14A
<TEXT>
Document 1 - file: a2024proxy-defa14a.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>cumberlandlogoa02a01a.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 2 - file: cumberlandlogoa02a01a.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>xa01a.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 3 - file: xa01a.jpg

</DOCUMENT>
</SEC-DOCUMENT>